The FINANCIAL — Takeda Pharmaceutical Company Limited (“Takeda”) announced on April 1 that it has signed an agreement with Osaka Gas Chemicals Co., Ltd. (Head Office: Nishi-ku, Osaka City, “OGC”), a wholly owned subsidiary of Osaka Gas Co., Ltd., to transfer all the shares Takeda owns in Mizusawa Industrial Chemicals, Ltd. (Head Office: Chuo-ku, Tokyo, “Mizusawa”) to OGC and completed the transfer. Mizusawa is a subsidiary of OGC, and OGC will proceed with the acquisition of Mizusawa’s shares from other shareholders.
Mizusawa was established in 1937, aimed for the domestic manufacture of activated clay used for refining oil and fats. Its current major business areas include the manufacture and marketing of adsorbent materials with activated clay as the main product and also of resin additives such as functional resin fillers and stabilizers for polyvinyl chlorides (PVC) resin as the main products.
Takeda is committed to achieving sustainable growth by conducting priority investment of R&D resources on promising R&D pipelines including gastroenterology and oncology and aggressive investment in emerging markets which will drive its business. Taking into consideration the future development of Mizusawa’s business, Takeda is confident that OGC, one of the core companies of Osaka Gas Group which conducts a wide range of business including carbon fiber, fibrous activated carbon and adsorbent, will develop the future business of Mizusawa leveraging the synergy of the businesses between the both companies. Hence, Takeda has decided to transfer the shares it owns in Mizusawa to OGC.
Takeda continues to place a patient and customer centric mindset as our top priority and operate more efficiently and competitively while aiming to realize its goal of becoming a more agile, best-in-class pharmaceutical company.
Discussion about this post